Maganti Nenita, Squires Natalie, Mishra Shubhendu, Bomdica Prithvi, Nigam Divya, Shapiro Arthur, Gill Manjot K, Lyon Alice T, Mirza Rukhsana G
Department of Ophthalmology, Northwestern University, Chicago, IL, USA.
Department of Psychology and Department of Computer Science, American University, Washington, DC, USA.
Clin Ophthalmol. 2022 Feb 25;16:507-515. doi: 10.2147/OPTH.S342188. eCollection 2022.
This study was performed to characterize changes in contrast sensitivity (CS) that occur in patients with age-related macular degeneration (AMD) using a novel test, the motion diamond stimulus (MDS).
This was a cross-sectional study in which 20 subjects with unilateral exudative AMD (eAMD) and contralateral dry AMD received 3 assessments: the Pelli-Robson (PR) CS Chart, the MDS test, and a visual function questionnaire-25 (VFQ-25). CS results from the PR, and MDS tests were compared across 3 groups: eyes with eAMD vs dry AMD, eAMD vs control, dry AMD vs control. Healthy, undilated eyes from another study served as the control group. Significance was determined using ANOVA analysis for the MDS output parameters (α: overall contrast threshold, β: adaptability of the visual system) and PR logCS. Patients were also administered the VFQ-25 to assess vision-related quality of life.
The ANOVA of the MDS data demonstrated a significant difference in visual function according to the β parameter of the 3 groups, but no significant difference in the α parameter. PR CS results for the 3 groups were significantly different, further supporting the MDS results. Post-hoc analysis showed a significant difference in β and PR log CS between the eAMD and control eyes.
The MDS test is valuable in discerning CS impairments in patients with AMD. It can provide further insight into the visual changes experienced by patients with AMD and has potential to quantify visual function changes that are not found on visual acuity testing alone.
本研究旨在使用一种新型测试——运动菱形刺激(MDS)来表征年龄相关性黄斑变性(AMD)患者对比敏感度(CS)的变化。
这是一项横断面研究,20名单侧渗出性AMD(eAMD)和对侧干性AMD患者接受了3项评估:佩利-罗布森(PR)CS图表、MDS测试和视觉功能问卷-25(VFQ-25)。将PR和MDS测试的CS结果在3组中进行比较:eAMD眼与干性AMD眼、eAMD眼与对照组、干性AMD眼与对照组。另一项研究中健康、未散瞳的眼睛作为对照组。使用方差分析确定MDS输出参数(α:总体对比阈值,β:视觉系统的适应性)和PR logCS的显著性。还对患者进行了VFQ-25评估与视力相关的生活质量。
MDS数据的方差分析表明,根据3组的β参数,视觉功能存在显著差异,但α参数无显著差异。3组的PR CS结果有显著差异,进一步支持了MDS结果。事后分析显示,eAMD眼与对照眼之间的β和PR log CS存在显著差异。
MDS测试在识别AMD患者的CS损伤方面具有重要价值。它可以进一步深入了解AMD患者所经历的视觉变化,并有可能量化仅通过视力测试无法发现的视觉功能变化。